Innovation in Cardiac Arrhythmia Treatment

With the support of funding from the Filum Foundation, research and development are being carried out on CryoCordia, an innovative dual-catheter system designed to treat complex cardiovascular conditions. Atrial fibrillation is the most common cardiac arrhythmia worldwide. Existing ablation techniques often fall short in treating complex or persistent forms of this condition. The development of CryoCordia aims to make effective treatment possible for even the most complex cases.